Emergence of azole-resistantCandida parapsilosiscausing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa

Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method

(2015) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Invasive Candidiasis

(2015) Bart Jan Kullberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Declining Incidence of Candidemia and the Shifting Epidemiology of Candida Resistance in Two US Metropolitan Areas, 2008–2013: Results from Population-Based Surveillance

(2015) Angela Ahlquist Cleveland et al.   PLoS One

Molecular Mechanisms of Fluconazole Resistance in Candida parapsilosis Isolates from a U.S. Surveillance System

(2014) Nina T. Grossman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole

(2014) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

(2014) O.A. Cornely et al.   CLINICAL MICROBIOLOGY AND INFECTION

Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria

(2014) Michael A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

(2013) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Candidemia among adults in Soweto, South Africa, 1990–2007

(2013) Adrian Kreusch et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria

(2013) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole for Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method

(2013) E. Canton et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Background changing patterns of neonatal fungal sepsis in a developing country

(2013) D. E. Ballot et al.   JOURNAL OF TROPICAL PEDIATRICS

Candida parapsilosis Is a Significant Neonatal Pathogen

(2013) Mohan Pammi et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey

(2013) Marcio Nucci et al.   PLoS One

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

(2012) A.J. Ullmann et al.   CLINICAL MICROBIOLOGY AND INFECTION

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

(2012) O.A. Cornely et al.   CLINICAL MICROBIOLOGY AND INFECTION

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

(2012) W.W. Hope et al.   CLINICAL MICROBIOLOGY AND INFECTION

Comparison of Three Statistical Methods for Establishing Tentative Wild-Type Population and Epidemiological Cutoff Values for Echinocandins, Amphotericin B, Flucytosine, and Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method

(2012) E. Canton et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011

(2012) S. R. Lockhart et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia

(2011) Maiken Cavling Arendrup et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

(2010) M. Castanheira et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Utility of a Luminex-based assay for multiplexed, rapid species identification of Candida isolates from an ongoing candidemia surveillance

(2010) Eszter Deak et al.   CANADIAN JOURNAL OF MICROBIOLOGY

Comparative Efficacy of Echinocandins and Nonechinocandins for the Treatment ofCandida parapsilosisInfections: A Meta-analysis

(2010) Pramodini B Kale-Pradhan et al.   PHARMACOTHERAPY

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility

(2008) G. Garcia-Effron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Epidemiology of Candidemia: Evidence of Clusters of Smoldering Nosocomial Infections

(2008) Lena Rós Ásmundsdóttir et al.   CLINICAL INFECTIOUS DISEASES

Geographic and Temporal Trends in Isolation and Antifungal Susceptibility of Candida parapsilosis: a Global Assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY